TGFβ-induced growth inhibition involves cell cycle inhibitor p21 and pRb independent from p15 expression

被引:0
作者
Voss, M
Wolff, B
Savitskaia, N
Ungefroren, H
Deppert, W
Schmiegel, W
Kalthoff, H
Naumann, M
机构
[1] Max Planck Inst Infekt Biol, Mol Biol Abt, D-10117 Berlin, Germany
[2] Univ Kiel Klinikum, Abt Thoraxchirurg & Allgemiene Chirurg, D-24105 Kiel, Germany
[3] Ruhr Univ Bochum, Med Klin, D-44892 Bochum, Germany
[4] Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany
关键词
cell cycle inhibitors; TGF beta; pRb; p15; p16; p21;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is generally assumed that TGF beta induces cell cycle arrest through the cooperative action of cell cycle inhibitors p15, p27 and p21. Here, we found that several pancreatic carcinoma cell lines exert TGF beta-induced negative growth control in spite of the loss of p15 and p16 expression. In these cell lines, TGF beta-induced growth control correlates with the upregulation of the p21 protein and active pRb expression. Conversely, cells without p21 and/or pRb expression are resistant to TGF beta-induced growth inhibition. Moreover, overexpression of p21 in the p21-deficient cell line Pane Tu1 leads to growth arrest. Thus, TGF beta-induced growth control correlates with p21 expression and pRb status independent of p15 and/or p16 expression.
引用
收藏
页码:93 / 101
页数:9
相关论文
共 26 条
[11]   Downregulation of microRNA-95-3p suppresses cell growth of osteosarcoma via CDKN1A/p21 expression [J].
Zhao, Xin ;
Yang, Yukai ;
Xu, Jianting ;
Luo, Yang ;
Xin, Ying ;
Wan, Yanbing .
ONCOLOGY REPORTS, 2018, 39 (01) :289-297
[12]   TGF-beta mediated G(1) arrest in a human melanoma cell line lacking p15(INK4B): Evidence for cooperation between p21(Cip1/WAF1) and p27 [J].
Florenes, VA ;
Bhattacharya, N ;
Bani, MR ;
BenDavid, Y ;
Kerbel, RS ;
Slingerland, JM .
ONCOGENE, 1996, 13 (11) :2447-2457
[13]   Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-β1-induced expression of p15/INK4B [J].
Frost, SJ ;
Simpson, DJ ;
Farrell, WE .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 176 (1-2) :29-37
[14]   Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells [J].
Choi, YH ;
Choi, BT ;
Lee, WH ;
Rhee, SH ;
Park, KY .
ONCOLOGY REPORTS, 2001, 8 (05) :1091-1096
[15]   Targeting the TGF-β-p21 axis: a critical regulator of bleomycin-induced cell cycle arrest and apoptosis in vitro-implication for progressive cervical cancer therapy [J].
Shrivastava, Somi ;
Ratnacaram, Chandrahas Koumar .
MEDICAL ONCOLOGY, 2025, 42 (04)
[16]   Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression [J].
Koo, Bon-Hun ;
Kim, Yeaji ;
Cho, Yang Je ;
Kim, Doo-Sik .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 764 :413-423
[17]   Microgravity Induces Pelvic Bone Loss through Osteoclastic Activity, Osteocytic Osteolysis, and Osteoblastic Cell Cycle Inhibition by CDKN1a/p21 [J].
Blaber, Elizabeth A. ;
Dvorochkin, Natalya ;
Lee, Chialing ;
Alwood, Joshua S. ;
Yousuf, Rukhsana ;
Pianetta, Piero ;
Globus, Ruth K. ;
Burns, Brendan P. ;
Almeida, Eduardo A. C. .
PLOS ONE, 2013, 8 (04)
[18]   P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition [J].
Al-Azayzih, Ahmad ;
Gao, Fei ;
Somanath, Payaningal R. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2015, 1853 (05) :1229-1239
[19]   Suppression of human prostate cancer cell growth by β-lapachone via down-regulation of pRB phosphorylation and induction of Cdk inhibitor p21WAF1/CIP1 [J].
Choi, YH ;
Kang, HS ;
Yoo, MA .
JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 36 (02) :223-229
[20]   Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-β-induced cell cycle arrest of gastric carcinoma cells [J].
Kang, SH ;
Bang, YJ ;
Jong, HS ;
Seo, JY ;
Kim, NK ;
Kim, SJ .
BRITISH JOURNAL OF CANCER, 1999, 80 (08) :1144-1149